When paired with guidance and accountability, these injections offer transformative results
Younger patients and those with higher baseline metabolic rates sometimes notice effects within days
Independent of hemodynamic effects, from a metabolic perspective, SGLT2 inhibitors promote glucosuria and modestly improve glycemic control [15,16]
In doing so, oral formulations could support the normalisation of obesity management making initiation simpler for general practitioners and reducing the stigma that continues to limit the uptake of injectable therapies
However, as with any medical treatment, some individuals may experience mild to moderate reactions
Common side effects Nausea Diarrhea or constipation Vomiting Abdominal pain Fatigue Serious risks Pancreatitis (inflammation of the pancreas) Gallbladder problems Low blood sugar, especially with other diabetes medicines Kidney problems related to dehydration Serious allergic reactions Do not use if you have Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known serious allergy to semaglutide Pregnancy or breastfeeding How it compares Frequently asked questions What is compounded semaglutide
)
